This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Bird Flu Sends China's Drug Stocks Flying

BEIJING ( TheStreet) -- Stock advisers are telling Chinese investors to take a gander at drug and medical supply companies now that a deadly strain of bird flu is spreading on the eve of the country's annual Spring Festival travel blitz.

Buy signals have been flashing this week for vaccine manufacturer Hualan Biological, virus test kit specialist Da An Gene and drug maker Shanghai Kai Bao Pharmaceutical.

Analysts have also recommended shares in makers of traditional Chinese medicines designed to fight viruses and prevent disease. Recommended stocks included Yiling Pharmaceutical and Guangzhou Pharmaceutical.

Hualan has been working on an H7N9 vaccine since last year, when it got a green light from the World Health Organization to develop the product. A government drug regulator for China's Henan Province registered the vaccine January 3, clearing the way for clinical trials.

Meanwhile, the traditional Chinese medicine supplier Lianghua Qingwen, which is not listed, has been stoking public interest in bird flu drugs by advertising a product it makes from rare Tibetan plants as an immune system-booster that prevents H7N9.

On the Shanghai Stock Exchange, Hualan saw its stock value slip 0.1% Thursday in heavy trading to close at 29.43 yuan. Guangzhou's shares fell 0.3% to finish at 26.33 yuan.

On the Shenzhen exchange Thursday, shares in Kai Bao jumped 3.7% to close at 17.48 yuan, Da An stock rose 2.8% to finish the day at 15.66 yuan, and Yiling gained 2.1% to 34.93 yuan.

Since Jan. 1, health authorities say more than 40 people in Shanghai and four provinces have been confirmed to have been infected with the H7N9 strain of bird flu, which officials say is transmitted from live birds to people but not from human to human.

At least two people have died so far this month, coincidentally on the same day in Shanghai, according to China's National Health and Family Planning Commission. A 31-year-old man and a 77-year-old woman were admitted to separate hospitals Jan. 17 and died the next day.

The outbreak comes as hundreds of millions of migrant workers, university students and others prepare to travel to their hometowns for the traditional Spring Festival holiday period, which begins with the Chinese New Year celebration Jan, 31. Health officials fear travelers carrying live poultry could spread H7N9 infections.

-- Written by Eric Johnson in Beijing

At the time of publication the author had no position in the companies mentioned.

 

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,778.15 +421.28 2.43%
S&P 500 2,061.23 +48.34 2.40%
NASDAQ 4,748.3960 +104.0840 2.24%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs